Programme
Register to attend
| 08:45 | Registration and refreshments | Auditorium Foyer |
| 09:10 |
Welcome and overview of the event Martin Bennett: Director, BHF Cambridge Centre for Cardiovascular Research Excellence |
Auditorium (all talks/ unless otherwise specified) |
| 09:15 |
Distinguished guest speaker: Marianna Fontana, Professor of Cardiology, University College London |
Understanding mechanisms and precision treatment of amyloid cardiomyopathy |
|
Session 1: New Insights from Multimodality Studies in Cardiovascular and Cardiometabolic Disease |
Chair: Sue Ozanne | |
| 09:55 |
Sam Lambert, Assistant Professor, Cardiovascular Epidemiology Unit, University of Cambridge |
Genetic investigation of the overlap between CAD and T2D identifies discordant risks of liver fat accumulation |
| 10:10 |
Antonio Vidal Puig, Professor of Molecular Nutrition and Metabolism, Institute of Metabolic Science, University of Cambridge |
Cardiometabolic disease as a systems problem: a vision for Cambridge and beyond |
| 10:25 |
Mayank Dalakoti, PhD candidate, Department of Public Health and Primary Care, University of Cambridge |
Cardiometabolic disease prevention from a global context |
| 10:40 |
Poster previews session Theme 1: Jennifer Jardine Theme 2: Nikolai Pakhomov Theme 3: Stefano Boriati Theme 4: Rachael Crew Theme 5: Sheikh Umara Zoni |
Lightning talks from selected poster presenters |
| 10:55 |
Refreshments and poster session A |
Dining Hall |
| Session 2: Prevention, Treatment and Regeneration in Heart Failure |
Chair: Catherine Wilson |
|
| 11:30 |
Lay Ping Ong, AstraZeneca Research Fellow, Department of Pharmacology, University of Cambridge |
Form and function in the regenerated rat heart |
| 11:45 | Ana Vujic, Assistant Professor and BHF Intermediate Fellow, Department of Medicine, University of Cambridge |
Exercise and cardiometabolic disease |
| 12:00 |
Robert Fletcher, PhD candidate, Department of Public Health and Primary Care, University of Cambridge |
Hospitalised heart failure with reduced versus preserved ejection fraction in England |
| 12:15 |
Laura Donnelly, Associate Director, Technology Development and Licensing, Cambridge Enterprise and Ash Earl, Senior Associate, Gill Jennings and Every LLP |
From ideas to impact: making the most of your IP |
| 12:35 |
Bryan Williams, Chief Scientific and Medical Officer, British Heart Foundation
|
BHF Research Strategy - Our portfolio of funding opportunities |
| 13:00 |
Lunch Chat to our 'Making the most of your IP' session speakers from 13:30 - 14:00 Poster session B from 13:40 - 14:15 |
Dining Hall and Dining Hall Balcony
|
| 14.25 |
Rouchelle Sriranjan Rothwell, NIHR clinical lecturer in Cardiology, Department of Medicine and Nick Evans, Senior Clinical Lecturer, Department of Clinical Neurosciences, University of Cambridge |
East of England Patient and Public Involvement and Engagement in cardiovascular research |
| Session 3: Small Vessel Disease and Development | Chair: Tian Zhao | |
| 14:45 |
Wei Li, Research Professor and BHF Senior Basic Science Research Fellow, Department of Medicine, University of Cambridge |
Does endoglin play a role in endothelial and adipose tissue crosstalk? |
| 15:00 |
Maria Köhne, Research Associate, Cambridge Stem Cell Institute
|
Spatiotemporal benchmarking of endocardial sprouting and state dynamics during human coronary vessel development |
| 15:15 |
Oriane Marguet, PhD candidate, Dept Clinical Neurosciences, University of Cambridge |
Inflammation and cerebral small vessel disease severity – insights from the INSVD study |
| 15:30 |
Refreshments |
Dining Hall |
|
Session 4: Inherited, acquired and Immune drivers of CVD |
Chair: James Cranley | |
| 16:00 |
Emanuele Di Angelantonio, Professor of Clinical Epidemiology and Donor Health, BHF Cardiovascular Epidemiology Unit, University of Cambridge |
CVRisk-it: biochemical and genetic factors in CVD |
| 16:15 | Paul Carter, Clinical Lecturer, Department of Medicine, University of Cambridge |
Clonal haematopoiesis in cardiovascular disease: how the genetic driver, sex, and disease context matter |
| 16:30 |
James 0`Brien, Clinical Research Associate, Department of Medicine, University of Cambridge |
The impact of modulating the adaptive immune system on the B cell repertoire in acute coronary syndromes |
| 16:45 |
Distinguished guest speaker Muredach Reilly, Professor of Medicine at Columbia University, New York |
Stromal cells in atherosclerosis: a genomics perspective |
| 17:25 | Poster prizes and closing remarks | Martin Bennett |
| 17:45 | Post-event networking with drinks and nibbles. Please stay to catch up with anyone you may have missed earlier | Dining Hall |
